-
Mashup Score: 1
The Vaccine Response On/Off Methotrexate (VROOM) study by Abhishek Abhishek and colleagues1 marks a key milestone in our understanding of vaccine response in the context of immunosuppression. The authors investigated the effect of a 2-week break in methotrexate treatment on the immunogenicity of a COVID-19 booster vaccine. The study was a randomised parallel-group, superiority trial of 383 people with immune-mediated inflammatory diseases including rheumatoid arthritis, psoriasis, and psoriatic arthritis, on methotrexate therapy.
Source: www.thelancet.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 3AAD.org Login - 8 month(s) ago
Create a non-member account if you are applying for members hip or need to interact with AAD systems. Non-member accounts do not have access to the member-only sections of our
Source: identity.aad.orgCategories: Dermatology, Latest HeadlinesTweet-
An @intjderm article evaluated the drug survival of #methotrexate in patients with #psoriasis and assessed the clinical course to determine factors associated with drug discontinuation. #DermWorldWeekly https://t.co/29I9mbDRYa https://t.co/mXJ1MBErQn
-
-
Mashup Score: 2Psoriasis Treatment: Methotrexate -- A Guide for Patients - 9 month(s) ago
Methotrexate is a strong medicine. The FDA approved it to treat adults with severe, disabling psoriasis that cannot be controlled with medicine applied to the skin or light treatments.
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
The FDA approved #methotrexate to treat adults with severe, disabling #psoriasis that cannot be controlled with medicine applied to the skin or light treatments. #AADReadingRoom @AADskin #dermatology Read more: https://t.co/xvfcoZI0fW https://t.co/PAeLAOnZkt
-
-
Mashup Score: 0Treatment Burden for Methotrexate and TNF Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study - 10 month(s) ago
An American College of Rheumatology Reading Room selection
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Objective: To describe patients' perspectives on the burden associated with #methotrexate or tumor necrosis factor inhibitor use in #psoriatic arthritis and #rheumatoid arthritis. #Rheumatology @ACRheum Read more: https://t.co/FVKmfH88SY https://t.co/pwPAzJjY1e
-
-
Mashup Score: 2Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD) - 10 month(s) ago
AbstractObjectives. Methotrexate (MTX), leflunomide (LEF) and sulfasalazine (SSZ) are conventional synthetic disease-modifying drugs (csDMARDs) with a well-esta
Source: OUP AcademicCategories: Latest Headlines, RheumatologyTweet-
NEW results from the NOR-DMARD study evaluate adverse events & #DMARD discontinuation in the real 🌍: ⭐ Discontinuation ⬆ for #leflunomide & #sulfasalazine vs #methotrexate ⭐ Non-medical aspects play a role in acceptance of AEs 📖 👇 https://t.co/oW6d8u3rod https://t.co/Hm3iaHZ8h4
-
-
Mashup Score: 0Genome-wide investigation of persistence to treatment with methotrexate in early rheumatoid arthritis - 10 month(s) ago
AbstractObjectives. To investigate the influence of genetic factors on persistence to treatment of early rheumatoid arthritis (RA) with methotrexate (MTX) monot
Source: OUP AcademicCategories: Latest Headlines, RheumatologyTweet-
The largest #GWAS results evaluating #methotrexate outcome in early #RheumatoidArthritis have found: ⭐ Modest polygenic component ⭐ ⬆ genetic predisposition to RA correlates to ⬇ persistence Read more on #AdvanceAccess 👇 https://t.co/lzIWsf2ecb
-
-
Mashup Score: 5Arthritis Foundation Statement: Navigating Nationwide Generic Medications Shortages - 11 month(s) ago
Here’s advice to help cope with shortages of methotrexate and other generic prescription drugs, including trying different pharmacies and calling our Helpline.
Source: www.arthritis.orgCategories: Latest Headlines, RheumatologyTweet-
If you're having trouble accessing your #methotrexate medication: ➡️ Contact your health care provider. ➡️ Contact other pharmacies in your community. ➡️ Call our helpline and share your experience at 1-800-283-7800. Learn more: https://t.co/FD1XzLVPbX https://t.co/9AT5ac6pPI
-
-
Mashup Score: 0Accurate Prediction Tool Developed for Methotrexate Monitoring in Long-Term Treatment - 11 month(s) ago
New prognostic model enhances methotrexate monitoring for immune-mediated inflammatory diseases.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
A new prognostic model revolutionizes monitoring, providing insights to optimize blood test frequency and enhance care for immune-mediated inflammatory diseases. #Methotrexate #Pasoriasis https://t.co/LIh94G7grX
-
-
Mashup Score: 0Methotrexate Usage Comparable Between Patients With PsA, RA - 11 month(s) ago
At the 2-year mark after methotrexate initiation, 71% of patients with psoriatic arthritis and 76% of patients with rheumatoid arthritis remained on methotrexate.
Source: HCP LiveCategories: Latest Headlines, RheumatologyTweet-
At the 2-year mark after #methotrexate initiation, 71% of patients with #PsoriaticArthritis and 76% of patients with #RheumatoidArthritis remained on methotrexate. https://t.co/OkDbeJ3wnB https://t.co/K1FtxoOCqH
-
-
Mashup Score: 0
Combination therapy with adalimumab plus low-dose methotrexate induced a two-fold reduction of treatment failure among pediatric patients with Crohn’s disease, according to research published in Gastroenterology. “Tumor necrosis factor inhibitors (TNFi), including infliximab and adalimumab, are a mainstay of pediatric Crohn’s disease therapy; however, non-response and loss of
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
According to @MichaelKappel12, #adalimumab plus #methotrexate lowers treatment failure 2-fold in #pediatric #Crohns @AGA_Gastro #IBD #GITwitter #MedTwitter https://t.co/ouFO1V0tdh
-
Improving COVID-19 vaccine response in individuals receiving #methotrexate Linked Comment by @katiebechman1 & @drjamesgalloway https://t.co/DOZmcZUJ2m https://t.co/0nLUOSEd9r